The medical community read more is intrigued by retatrutide, a novel dual GIP and GLP-1 agonist that’s showing significant results in early trials . This treatment works by mimicking natural hormones to affect appetite and boost feelings of fullness , ultimately leading substantial weight loss . While presently under evaluation and not broadly av